• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents

cafead

Administrator
Staff member
  • cafead   Apr 22, 2024 at 11:42: AM
via The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals (VNDA.O) to revive patents for its sleep-disorder drug Hetlioz that were previously declared invalid in a dispute with generic drugmakers Teva (TEVA.TA) and Apotex.

article source
 

<